b i o s y n t h e s i s r e p r e s e n t a heterogeneous group of metabolic disorders. The aim of the authors of this article is to present a case of a patient with typical symptoms of a rare post-squalene disorder of cholesterol biosynthesis, its diagnostics and progress in neonatal period. The differential diagnosis of a typical findings on the skin with spontaneous r e g r e s s i o n i c h t y o s i f o r m e r y t h r o d e r m a , c r a n i o f a c i a l dysmorphic features, anomalies of organs or skeletal abnormalities in a newborn may also be the result of a d i s o r d e r o f c h o l e s t e r o l biosynthesis. The final diagnosis is definitely confirmed by DNA analysis. Prognosis depends on the different enzyme defects of cholesterol biosynthesis pathway, but typically on the post-squalene pathway. Cholesterol is an important substance that plays a significant role in membrane structure, as well as being the precursor for the synthesis of the steroid hormones and bile acids. Cholesterol synthesis occurs in the cytoplasm and microsomes from the twocarbon acetate group of acetyl coenzyme A (acetyl-CoA). The biosynthesis of cholesterol consists of several reactions. 
Case report
The authors present the case of a female newborn with pathological findings. Growth retardation of long bones and polyhydramnion in the 32 week of gestation were found during pregnancy. The patient nd was born by caesarean section in the 39 week of gestation. Birth weight was 3360 grams and birth length was 41 centimeters (corresponding to the 3 percentile).Apgar score was 10/10. Skeletal dysplasias form a heterogeneous group of inherited diseases of the skeleton. They may arise from disorders of metabolism of cartilage, bone or ligament.
According to the international classification of osteochondrodysplasias they are divided into three main groups, including 1. defects of long and flat bones or axial skeleton, 2. pathological development of cartilage and fibrous components of the skeleton, and 3. idiopathic osteolysis.
Chondrodysplasia punctata type 2 (CDPX2) belongs to the first group and is a clinically and genetically heterogeneous disorder. It is characterized by punctiform calcification of the bones. It is an X-linked dominant genetic disorder also known as Conradisyndrome. Brachytelephalangic form of chondrodysplasia punctata was described by Sheffield in 1976. It is X-linked recessive form, which is caused by mutation in arylsulfatase E gene (ARSE). Zizka et al., 1998, reported two cases of rhizomelic chondrodysplasia punctata with distinctive phenotype and autosomal recessive type of inheritance.
Chondrodysplasia punctata type 2 is rare form of skeletal dysplasia. Its incidence and also prevalence is unknown. In all, approximately 50 cases have been reported in literature.
Molecular analysis can confirm the diagnosis. To date, there have been descriptions in literature which described 46 various mutations. In our case, the mutation of (c.386G>A) in the EBP gene encoding delta(8)-delta(7) sterol izomerase was detected in heterozygous state. Hűnermann-Happle coxae congenita. Mother's height in adulthood was 158 centimeters. Her 3-year-old elder sister was healthy.
At birth, short stature, asymmetrical shortening of the femora and humeri, flat face, saddle nose, coarse and sparse hair, wide neck with marked torticollis, transversal lines on the palms with marked ulnar deviation and right talipes equinovarus were all noted. Large hyperkeratotic irregular linear scales on erythrodermic background were found on skin (Fig  1) . Cutaneous lesion reminded of a collodion baby.
Fig 1
Radiography showed asymmetric shortening of the long bones and expanded metaphyseal femur, tibia and epiphyseal stippling of long bones (Fig 2) and the cartilage of ribs. Published cases in the literature have mostly been females, but X-linked dominant chondrodysplasia punctata may be inherited as a lethal form in hemizygous males.
Other EBP mutations have been reported with no evidence of correlation between phenotype of patients with CDPX2. There are even some studies that present marked variation in expressivity within the same mutation and the same family means, which signals that the phenotypic effect of a given mutation cannot be predicted, even within a family. This strong intrafamilial variation is of paramount importance when predicting the prognosis of a particular CDPX2 patient and providing genetic counseling to CDPX2 families. After a complete investigation of the patient's mother, it was found in our case that it was an isolated occurrence of mutation.
Prenatal diagnosis is available by finding mutations on amniocentesis or chorionic villus sampling. Kelley in 1999 found growth retardation, asymmetry of bone and polyhydramnios in fetuses in the second and third trimesters of gestations. In our case a significant growth retardation of long bones and polyhydramnios was detected prenatally in our patient by ultrasonography in the 32 week of gestation.
syndrome, is an X chromosomal dominant disorder of cholesterol biosynthesis. In neonatal age, it is necessary to think about this postsqualene disorder of cholesterol biosynthesis within the differential diagnosis of atypical findings on the skin, craniofacial dysmorphic features and asymmetric shortening of extremities or skeletal abnormalities and organ anomalies.
In affected patients, the analysis of sterols in plasma can lead to the detection of accumulation of 8-dehydrocholesterol or cholest-8(9)-enol. Radiographic changes show typical epiphyseal stippling of long bones, which can lead to diagnosis, but it is definitely confirmed by molecular genetic analysis.
Clinical findings were dominated by reversible skin lesions with spontaneous regression ichthyosiform Erythroderma, with the creation of systematic skin atrophy in infancy. The prognosis of patients with Conradi--Happle syndrome is good. Psychomotor development is usually normal, sometimes with mild retardation. Patients need dermatologic care and regular application of emollients. Limb asymmetry and scoliosis can lead to premature arthritis, which would require the cooperation with orthopedists.
Prenatal detection of significant shortening of long bones is an indication for postnatal complete genetic testing. Confirmed mutation leads to a premature stop codon of amino acid chain and then to a formation of truncated protein EBP with altered function confirming the diagnosis of CDPX2. Due to the of the gene's mutation, a defect of delta (8) -delta (7) sterol isomerase is formed, which is an enzyme that plays an important role in the last steps of postsqualene pathway of cholesterol biosynthesis. In this case it was an isolated occurrence in the family.
Dysmorphic features represent skin defects including linear or whorled atrophic and pigmentary lesions, striated hyperkeratosis, coarse lusterless hair and alopecia, cataract and craniofacial defects. On admission of the patient in our case, large hyperkeratotic irregular linear scales dominated on the skin. Skin findings improved spontaneously in the neonatal period. Currently, the 1-year-old girl's dry skin and follicular atrophoderma especially on the head persist. Gas chromatography/mass spectrometry (GC/MS) analysis revealed markedly elevated levels of 8-cholest-8(9)-en--ol and helped to identify somatic mosaicism in a clinically unaffected men.
Sutphen et al., 1995, reported of a male patient with X-linked dominant chondrodysplasia punctata and with a 47, XXY karyotype, who died at the age of 31 years due to restricted pulmonary disease secondary to severe kyphoscoliosis. Derry et al., 1999, suggested that the presence of toxic sterol intermediates may be associated with lethality in boys and assumed that some features of CDPX2 phenotype form direct defect of abnormal cholesterol biosynthesis. The exact mechanism by which the disrupted enzyme function leads to impaired morphogenesis in skin, eye and bone is unknown. 
